1-20 of 135
Larry W. Kwak
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Glofitamab stimulates immune cell infiltration of CNS tumors and induces clinical responses in secondary CNS lymphoma

James K. Godfrey, Lei Gao, Geoffrey Shouse, Joo Y. Song, Stacy Pak, Brian Lee, Bihong T. Chen, Avyakta Kallam, John H. Baird, Guido Marcucci, Lucy Ghoda, Stephanie Vauleon, Alexey V. Danilov, Alex F. Herrera, Larry W. Kwak, Lihua E. Budde
Journal: Blood
Blood (2024) 144 (4): 457–461.
https://doi.org/10.1182/blood.2024024168
Published: 2024
Includes: Supplemental data
Journal Articles

The Combination of Nivolumab and CC-486 Is Active in Hodgkin Lymphoma Refractory to PD-1 Blockade

Matthew G. Mei, Lu Chen, Sandrine Puverel, L. Elizabeth Budde, Swetha Kambhampati, Shari Daniels, Bev Dunning, Melissa Banez, Larry W. Kwak, Alex F. Herrera
Journal: Blood
Blood (2023) 142 (Supplement 1): 1697.
https://doi.org/10.1182/blood-2023-190753
Published: 2023
Journal Articles

Promising Safety and Anti-Lymphoma Efficacy of Autologous Pmb-CT01 (BAFFRCAR T Cell) Therapy in a First-in-Human Phase 1 Study

L. Elizabeth Budde, Marissa Morales Del Real, John H. Baird, Lu Chen, Joo Y. Song, Swetha Kambhampati, Alan Macias, Teresa Kim, Sylvia Dulan, Baishakhi Barva, Sandrine Puverel, Katrin Tiemann, Hazel Ting-Ying Cheng, Stephen J. Forman, Larry W. Kwak
Journal: Blood
Blood (2023) 142 (Supplement 1): 221.
https://doi.org/10.1182/blood-2023-183032
Published: 2023
Journal Articles

Early Intervention and Favorable Biologic Effects of Personalized Neoantigen Vaccines on the Tumor Immune Microenvironment in Smoldering Waldenstrom Macroglobulinemia

Szymon Szymura, Soungchul Cha, Lin Wang, Tiantian Zhang, Zhenyuan Dong, Aaron Anderson, Elizabeth Oh, Zhe Wang, Vincent Lee, Sapna Parshottham, Sheetal Rao, Jasper B Olsem, Brandon N Crumpton, Hans C. Lee, Elisabet E. Manasanch, Sattva S. Neelapu, Sheeba K. Thomas, Larry W. Kwak
Journal: Blood
Blood (2023) 142 (Supplement 1): 212.
https://doi.org/10.1182/blood-2023-182448
Published: 2023
Journal Articles

CD19-Directed CAR T-Cells (CD19-CAR) Combined with Acalabrutinib Achieves Durable Remissions in Patients with Relapsed or Refractory (r/r) Mantle Cell Lymphoma (MCL)

John H. Baird, Marissa Morales Del Real, Joo Y. Song, Geoffrey P. Shouse, Alexey Danilov, Alex F. Herrera, Leslie L. Popplewell, Steven T. Rosen, Jennifer Davis, Baishakhi Barva, Lu Chen, Larry W. Kwak, Stephen J. Forman, L. Elizabeth Budde
Journal: Blood
Blood (2023) 142 (Supplement 1): 4840.
https://doi.org/10.1182/blood-2023-182456
Published: 2023
Journal Articles

Cost-effectiveness of polatuzumab vedotin combined with chemoimmunotherapy in untreated diffuse large B-cell lymphoma

Clinical Trials & Observations
Swetha Kambhampati, Monica Saumoy, Yecheskel Schneider, Stacy Pak, Lihua Elizabeth Budde, Matthew G. Mei, Tanya Siddiqi, Leslie L. Popplewell, Yi-Ping Wen, Jasmine Zain, Stephen J. Forman, Larry W. Kwak, Steven T. Rosen, Alexey V. Danilov, Alex F. Herrera, Nikhil R. Thiruvengadam
Journal: Blood
Blood (2022) 140 (25): 2697–2708.
https://doi.org/10.1182/blood.2022016624
Published: 2022
Includes: Supplemental data
Journal Articles

Phase I Trial of Brentuximab Vedotin Plus Cyclosporine in Relapsed/Refractory Hodgkin Lymphoma

Swetha Kambhampati, Matthew Mei, Lu Chen, Sandrine Puverel, Robert Chen, Leslie L. Popplewell, Liana Nikolaenko, Lacolle Peters, Saro H. Armenian, Larry W. Kwak, Steve T Rosen, Stephen J Forman, Alex F. Herrera
Journal: Blood
Blood (2022) 140 (Supplement 1): 9418–9419.
https://doi.org/10.1182/blood-2022-157623
Published: 2022
Journal Articles

Development of a Novel Platform for in-Vitro Immune-Monitoring of Antigen-Specific T Cells and Discovery of Novel Antigen-Specific TCRs Using Immortalized B Cells Transfected with mRNA of Antigen Fused to Mitd (IBMAM)

Tiantian Zhang, Zhe Wang, Soung-chul Cha, Aaron Anderson, Jingwei Liu, Zhenyuan Dong, Szymon Szymura, Benjamin Kuang, Elizabeth Oh, Sattva S. Neelapu, Larry W. Kwak
Journal: Blood
Blood (2022) 140 (Supplement 1): 4699–4700.
https://doi.org/10.1182/blood-2022-157599
Published: 2022
Journal Articles

Nivolumab Plus ICE As First Salvage Therapy in High-Risk Relapsed/Refractory Hodgkin Lymphoma

Matthew Mei, Joycelynne Palmer, Ni-Chun Tsai, Hun Ju Lee, Iris Isufi, Leslie L. Popplewell, Lynne Smith, Lacolle Peters, Lara Rodriguez, James Godfrey, John H. Baird, Joo Y. Song, Steven T. Rosen, Larry W. Kwak, Stephen J Forman, Alex F. Herrera
Journal: Blood
Blood (2022) 140 (Supplement 1): 774–776.
https://doi.org/10.1182/blood-2022-167626
Published: 2022
Journal Articles

Polatuzumab Vedotin Combined with R-ICE (PolaR-ICE) As Second-Line Therapy in Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Alex F. Herrera, Lu Chen, Jennifer L. Crombie, Jonathon B. Cohen, Ranjana H. Advani, Ann S. LaCasce, Leslie L. Popplewell, Sandrine Puverel, Lacolle Peters, Shari Daniels, James Godfrey, Geoffrey Shouse, Matthew Mei, Swetha Kambhampati, L. Elizabeth Budde, Liana Nikolaenko, Steven T. Rosen, Larry W. Kwak, Stephen J Forman, Matthew J. Matasar
Journal: Blood
Blood (2022) 140 (Supplement 1): 1065–1067.
https://doi.org/10.1182/blood-2022-165699
Published: 2022
Journal Articles

Cost-effectiveness of second-line axicabtagene ciloleucel in relapsed refractory diffuse large B-cell lymphoma

Clinical Trials & Observations
Swetha Kambhampati, Monica Saumoy, Yecheskel Schneider, Steve Serrao, Pejman Solaimani, Lihua Elizabeth Budde, Matthew G. Mei, Leslie L. Popplewell, Tanya Siddiqi, Jasmine Zain, Stephen J. Forman, Larry W. Kwak, Steven T. Rosen, Alexey V. Danilov, Alex F. Herrera, Nikhil R. Thiruvengadam
Journal: Blood
Blood (2022) 140 (19): 2024–2036.
https://doi.org/10.1182/blood.2022016747
Published: 2022
Includes: Supplemental data
Journal Articles

A randomized phase 2 trial of idiotype vaccination and adoptive autologous T-cell transfer in patients with multiple myeloma

Clinical Trials & Observations
Muzaffar H. Qazilbash, Neeraj Y. Saini, Soung-chul Cha, Zhe Wang, Edward A. Stadtmauer, Veerabhadran Baladandayuthapani, Heather Lin, Beryl Tross, Medhavi Honhar, Sheetal S. Rao, Kunhwa Kim, Michael Popescu, Szymon Szymura, Tiantian Zhang, Aaron Anderson, Qaiser Bashir, Elizabeth J. Shpall, Robert Z. Orlowski, Bruce L. Levine, Naseem Kerr, Alfred Garfall, Adam Cohen, Dan T. Vogl, Karen Dengel, Carl H. June, Richard Champlin, Larry W. Kwak
Journal: Blood
Blood (2022) 139 (9): 1289–1301.
https://doi.org/10.1182/blood.2020008493
Published: 2022
Includes: Supplemental data
Journal Articles

CD19/BAFF-R Dual-Targeted CAR T Cells for the Treatment of Mixed Antigen-Negative Variants of Acute Lymphoblastic Leukemia

Xiuli Wang, Zhenyuan Dong, Wen-Chung Chang, Wesley Cheng, Vibhuti Vyas, Dennis Awuah, Soung-chul Cha, Aaron Anderson, Mary C. Clark, Stephen J Forman, Larry W. Kwak, Hong Qin
Journal: Blood
Blood (2021) 138 (Supplement 1): 2783.
https://doi.org/10.1182/blood-2021-151293
Published: 2021
Journal Articles

Brentuximab Vedotin Plus Cyclophosphamide, Doxorubicin, Etoposide, and Prednisone (CHEP-BV) Followed By BV Consolidation in Patients with CD30-Expressing Peripheral T-Cell Lymphomas

Alex F. Herrera, Jasmine Zain, Kerry J. Savage, Tatyana A. Feldman, Jonathan E Brammer, Lu Chen, Leslie L. Popplewell, Lihua E Budde, Matthew Mei, Lori A. Leslie, Ranjit Nair, Chitra Hosing, Lacolle Peters, Stephen J Forman, Steven T. Rosen, Larry W. Kwak, Swaminathan P Iyer
Journal: Blood
Blood (2021) 138 (Supplement 1): 133.
https://doi.org/10.1182/blood-2021-151105
Published: 2021
Journal Articles

Pembrolizumab Plus Vorinostat Induces Responses in Patients with Hodgkin Lymphoma Who Are Refractory to Prior PD-1 Blockade

Alex F. Herrera, Lu Chen, L. Elizabeth Budde, Saro Armenian, Liana Nikolaenko, Robert Chen, Shari Daniels, Neena Kennedy, Lacolle Peters, Steven T. Rosen, Stephen J Forman, Leslie L. Popplewell, Larry W. Kwak, Matthew Mei
Journal: Blood
Blood (2021) 138 (Supplement 1): 234.
https://doi.org/10.1182/blood-2021-150031
Published: 2021
Journal Articles

Long-Term Efficacy and Safety (27 months) of the Biosimilar CT-P10 in Patients with Low Tumor Burden Follicular Lymphoma

Larry W Kwak, MD PhD, Juan Manuel Sancho, MD PhD, Seok-Goo Cho, MD, PhD, Hideyuki Nakazawa, MD PhD, Junji Suzumiya, MD PhD, Gayane Tumyan, Jin Seok Kim, MD PhD, Tobias F Menne, MD PhD FRCPath, Jose Mario Mariz, Nikolai Ilyin, DMSc, MD PhD, Wojciech Jurczak, MD PhD, Aurelio Lopez Martínez, MD, Olga Samoilova, MD, Edvard Zhavrid, MD PhD, Eduardo Yanez Ruiz, MD, Marek Trneny, MD prof, Leslie L. Popplewell, MD FRCPA, Michinori Ogura, MDPhD, Won Seog Kim, MD PhD, Sang Joon Lee, PhD, Sung Hyun Kim, PhD, Keum Young Ahn, PhD, Christian Buske, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 27–28.
https://doi.org/10.1182/blood-2020-135999
Published: 2020
Journal Articles

Consolidation with Nivolumab and Brentuximab Vedotin after Autologous Hematopoietic Cell Transplantation in Patients with High-Risk Hodgkin Lymphoma

Alex F. Herrera, MD, Lu Chen, PhD, Yago Nieto, MD, Leona Holmberg, MD PhD, Patrick B. Johnston, Matthew Mei, MD, Leslie Popplewell, MD, Saro H. Armenian, DO, MPH, Thai Cao, MD, Len Farol, MD, Firoozeh Sahebi, MD, Ricardo Spielberger, MD, Robert Chen, MD, Auayporn P. Nademanee, MDBS, Lacolle Peters, Neena Kennedy, Steven T. Rosen, MD, Larry W Kwak, MD PhD, Stephen J. Forman, MD, Tatyana A. Feldman, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 19–20.
https://doi.org/10.1182/blood-2020-136384
Published: 2020
Journal Articles

Double-Hit Signature with TP53 Abnormalities Predicts Poor Survival in Patients with Germinal Center Type Diffuse Large B-Cell Lymphoma Treated with R-CHOP

Joo Y Song, MD, Anamarija M. Perry, MD, Alex F. Herrera, MD, Lu Chen, PhD, Pam Skrabek, MD, Michel Nasr, MD, Rebecca Ottesen, Janet Nikowitz, Victoria Bedell, Joyce Murata-Collins, PhD, Yuping Li, PhD, Christine McCarthy, Raju Pillai, MD, Jinhui Wang, PhD, Xiwei Wu, PhD, Jasmine M. Zain, MD, Leslie L. Popplewell, MD FACP, Larry W Kwak, MD PhD, Auayporn P. Nademanee, MDBS, Joyce Niland, PhD, David W. Scott, MBChB, PhD, Qiang Gong, PhD, Wing (John) C. Chan, MD, Dennis D. Weisenburger, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 25–26.
https://doi.org/10.1182/blood-2020-137258
Published: 2020
Journal Articles

A Novel Therapeutic DNA Vaccine Elicits Reduction of Tumor Clones and Favorable Perturbations in the Immune Microenvironment in Patients (pts) with Untreated Smoldering Waldenström Macroglobulinemia (sWM)

Sheeba K. Thomas, MD, Soung-chul Cha, PhD, Sapna R Parshottam, MSc, Sheetal S. Rao, PhD, Jasper B. Olsem, B.S.N., Brandon N. Crumpton, Szymon Szymura, PhD, Zhe Wang, PhD, Aaron Anderson, Lei Feng, MS, Hans C. Lee, MD, Elisabet E. Manasanch, MD, Krina K. Patel, MD, Donna M. Weber, MD, Robert Z. Orlowski, MDPhD, Sattva S. Neelapu, MD, Larry W Kwak, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 6–7.
https://doi.org/10.1182/blood-2020-140007
Published: 2020
Journal Articles

PET-Adapted Nivolumab or Nivolumab Plus ICE As First Salvage Therapy in Relapsed or Refractory Hodgkin Lymphoma

Alex F. Herrera, MD, Robert W. Chen, MD, Joycelynne Palmer, PhD, Ni-Chun Tsai, Matthew Mei, MD, Leslie L. Popplewell, MD FRCPA, Auayporn P. Nademanee, MDBS, Liana Nikolaenko, MD, Kathryn McBride, Ricardo Ortega, Joo Y. Song, MD, Steven Rosen, MD, Larry W Kwak, MD PhD, Stephen J Forman, MD, Hun Ju Lee, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 239.
https://doi.org/10.1182/blood-2019-123162
Published: 2019